NONSQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for NONSQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope in fight against spreading lung cancer: does adding a fourth drug help patients live longer?
Disease control CompletedThis study tested if adding a drug called lenvatinib to the standard three-drug treatment (chemotherapy plus immunotherapy) works better for adults in China with advanced lung cancer that has spread. The main goals were to see if the four-drug combo could slow the cancer's growth…
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Major trial tests Four-Drug attack on deadly lung cancer
Disease control CompletedThis large, completed Phase 3 trial tested whether adding a drug called lenvatinib to the standard first treatment (chemotherapy plus pembrolizumab) could better control advanced non-small cell lung cancer that had spread. It involved 761 adults and aimed to see if the four-drug …
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC